Gemma Postill

Gemma Postill

Auto-generated profile, based on publicly available information

Gemma Postill

Temerty Faculty of Medicine, Temerty Centre for AI Research Education and Medicine (T-CAIREM), University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2024 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
MCMichael Colacci
Michael Colacci
YHYu Qing Huang
Yu Qing Huang
GPGemma Postill
Gemma Postill
PZPavel Zhelnov
Pavel Zhelnov
OFOrna Fennelly
Orna Fennelly
ATAndrea C. Tricco
Andrea C. Tricco
Clinical machine learning (ML) technologies can sometimes be biased and their use could exacerbate health disparities. The extent to which bias is present, the groups who most frequently experience bias, and the mechanism through which bias is introduced in clinical ML applications is not well described. The objective of this study was to examine instances of bias in clinical ML models. We identified the sociodemographic subgroups PROGRESS that experienced bias and the reported mechanisms of bias introduction. We searched MEDLINE, EMBASE, PsycINFO, and Web of Science for all studies that evaluated bias on sociodemographic factors within ML algorithms created for the purpose of facilitating clinical care. The scoping review was conducted according to the Joanna Briggs Institute guide and reported using the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) extension for scoping reviews. We identified 6448 articles, of which 760 reported on a clinical ML model and 91 (12.0%) completed a bias evaluation and met all inclusion criteria. Most studies evaluated a single sociodemographic factor (n = 56, 61.5%). The most frequently evaluated sociodemographic factor was race (n = 59, 64.8%), followed by sex/gender (n = 41, 45.1%), and age (n = 24, 26.4%), with one study (1.1%) evaluating intersectional factors. Of all studies, 74.7% (n = 68) reported that bias was present, 18.7% (n = 17) reported bias was not present, and 6.6% (n = 6) did not state whether bias was present. When present, 87% of studies reported bias against groups with socioeconomic disadvantage. Most ML algorithms that were evaluated for bias demonstrated bias on sociodemographic factors. Furthermore, most bias evaluations concentrated on race, sex/gender, and age, while other sociodemographic factors and their intersection were infrequently assessed. Given potential health equity implications, bias assessments should be completed for all clinical ML models.

21 February 2022 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
GPGemma Postill
Gemma Postill
RMRegan Murray
Regan Murray
AWAndrew S Wilton
Andrew S Wilton
RWRichard A Wells
Richard A Wells
RSRenee Sirbu
Renee Sirbu
Laura RosellaLaura Rosella
Laura Rosella
Background: Early estimates of excess mortality are crucial for understanding the impact of COVID-19. However, there is a lag of several months in the reporting of vital statistics mortality data for many jurisdictions, including across Canada. In Ontario, a Canadian province, certification by a coroner is required before cremation can occur, creating real-time mortality data that encompasses the majority of deaths within the province. Objective: This study aimed to validate the use of cremation data as a timely surveillance tool for all-cause mortality during a public health emergency in a jurisdiction with delays in vital statistics data. Specifically, this study aimed to validate this surveillance tool by determining the stability, timeliness, and robustness of its real-time estimation of all-cause mortality. Methods: Cremation records from January 2020 until April 2021 were compared to the historical records from 2017 to 2019, grouped according to week, age, sex, and whether COVID-19 was the cause of death. Cremation data were compared to Ontario’s provisional vital statistics mortality data released by Statistics Canada. The 2020 and 2021 records were then compared to previous years (2017-2019) to determine whether there was excess mortality within various age groups and whether deaths attributed to COVID-19 accounted for the entirety of the excess mortality. Results: Between 2017 and 2019, cremations were performed for 67.4% (95% CI 67.3%-67.5%) of deaths. The proportion of cremated deaths remained stable throughout 2020, even within age and sex categories. Cremation records are 99% complete within 3 weeks of the date of death, which precedes the compilation of vital statistics data by several months. Consequently, during the first wave (from April to June 2020), cremation records detected a 16.9% increase (95% CI 14.6%-19.3%) in all-cause mortality, a finding that was confirmed several months later with cremation data. Conclusions: The percentage of Ontarians cremated and the completion of cremation data several months before vital statistics did not change meaningfully during the COVID-19 pandemic period, establishing that the pandemic did not significantly alter cremation practices. Cremation data can be used to accurately estimate all-cause mortality in near real-time, particularly when real-time mortality estimates are needed to inform policy decisions for public health measures. The accuracy of this excess mortality estimation was confirmed by comparing it with official vital statistics data. These findings demonstrate the utility of cremation data as a complementary data source for timely mortality information during public health emergencies.

18 November 2025 in Communications Medicine
Verified
Journal Article
Open access
GPGemma Postill
Gemma Postill
VHVinyas Harish
Vinyas Harish
IIIjeoma Uchenna Itanyi
Ijeoma Uchenna Itanyi
FTFurong Tang
Furong Tang
EBEmma Buajitti
Emma Buajitti
EBEric I. Benchimol
Eric I. Benchimol
Multimorbidity is the co-occurrence of two or more chronic conditions in one person. Providing quality, patient-centered care requires understanding multimorbidity. Our objective was to identify patterns of multimorbidity that occur prior to death among people with inflammatory bowel disease (IBD). Using a retrospective population-based matched cohort derived from linked health administrative data of individuals with and without IBD who died between 2010 and 2020 in Ontario, Canada, we compared multimorbidity accumulation and leveraged unsupervised machine learning to identify multimorbidity clusters. Here we show decedents with IBD have a greater prevalence of complex multimorbidity (42% vs 34% with 8+ conditions, standardized difference: 22%). Among those with IBD at death, IBD is commonly developed as their first condition. At death, people with IBD have high prevalences of osteo- and other arthritis (77%), hypertension (73%), mood disorders (69%), renal failure (50%) and cancer (46%). Among those with IBD, we identify 3 clusters: ( α ) mood disorder and/or osteo- and other arthritis; ( β ) cancer and low multimorbidity; ( γ ) cardiovascular comorbidities. The clusters that we identify are stable across numerous validation techniques, including re-derivation and sex-specific clustering. These findings can inform future research and potential multimorbidity care in populations with IBD. Consideration of these clusters also lends to the need for further research, guidelines, and care programs to manage distinct subgroups of comorbidities among those with IBD, highlighting avenues for greater personalized care.

1 July 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
GPGemma Postill
Gemma Postill
ADAnglin Dent
Anglin Dent
JDJill Dombroski
Jill Dombroski
AVAmol A. Verma
Amol A. Verma
JMJeff Myers
Jeff Myers
TATavis Apramian
Tavis Apramian
As technology for artificial intelligence (AI) in medicine has rapidly proliferated, research is needed on how AI should be used in healthcare. Family physicians could deploy AI to predict survival in serious illness which is a particularly difficult task given the breadth of diseases encountered in primary care. Little research exists to inform whether survival estimation tools are welcome in primary care to manage serious illness prognostication. To address this gap, we elicited the perspectives of family medicine residents on the potential use of AI to help them predict survival (i.e., time expected) for their patients with serious illness. Our qualitative study draws on semi-structured interview data from 18 family medicine residents in Canada. We used a pragmatic framework to conduct our analysis, employing principles of constructivist grounded theory. We identified that family medicine residents were receptive to AI survival estimation for serious illness management, particularly for supporting their delivery of expert advice over a broad range of clinical topics. However, caring for patients with serious illness in primary care involves more than survival estimation, with such a tool having likely only limited applicability to end of life. Summarizing these perspectives, we identified four themes: (1) improving patient care with AI, (2) AI with a grain of salt, (3) patient-driven use of AI, and (4) augmenting, not replacing family physicians. Thus, survival estimation with AI for serious illness has potential clinical value in primary care. In addition to survival, pertinent challenges to address with AI include understanding of expected function, maximizing quality of life, and response to interventions, in addition to quantifying survival time. Future prognostication models should consider use of additional patient-centered outcomes and modifying the outcomes predicted based on prediction timepoints. To successfully deploy these technologies in primary care, additional education and role modelling of technology use is needed.

14 March 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
GPGemma Postill
Gemma Postill
MHMichael Halpin
Michael Halpin
CZClaire Zanin
Claire Zanin
CRCaroline Ritter
Caroline Ritter
Objectives This qualitative study aimed to explore how young adults experienced the COVID-19 pandemic in relation to extensive lockdowns, social isolation and psychosocial distress. Specifically, this research focused on how the pandemic impacted those who did not contract COVID-19 and lived in a low-risk geographical location. The focus was young adults given they have large social circles (high risk for disease transmission) and have an increased propensity to mental health conditions. These insights can inform planning for future pandemics. Design This paper draws on 30 in-depth semistructured interviews. Data were analysed inductively following the principles of a constructivist grounded theory approach. Setting and participants 30 young adults living in Prince Edward Island during the COVID-19 pandemic, a Canadian province with a low number of COVID-19 cases at the time of data collection. Results We developed four themes that describe the experience of young adults during the COVID-19 pandemic: (1) life course disruption, (2) fear and anxiety about the COVID-19 virus, (3) isolation and loss of hope and (4) strategies for managing adversity. Our findings highlight the areas of young adults’ lives that were affected by extensive social changes related to the COVID-19 pandemic. We demonstrate that even individuals who had not contracted the virus were considerably impacted. Conclusion We provide a detailed description of the comprehensive impact of COVID-19 on low-risk young adults not previously infected with the COVID-19 virus. By reflecting on the biographical disruption experienced by young adults, we highlight the need and opportunity to direct healthcare resources towards identifying and addressing the secondary impacts of pandemics. Consequently, these findings can guide decisions relating to future pandemic restrictions to better account for the experiences of individuals living through them.

2 April 2025 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
GPGemma Postill
Gemma Postill
JIJames H. B. Im
James H. B. Im
FTFurong Tang
Furong Tang
EBEric I. Benchimol
Eric I. Benchimol
MKM. Ellen Kuenzig
M. Ellen Kuenzig